Reservado el derecho a modificaciones · M-1892-FLY-ES-ES-BHCL-00-032025 Información para pedidos BioHorizons Camlog Ibérica Calle Oruro 9 | 28016 Madrid | España Tel 91 713 10 84 | pedidos@biohorizons.com | www.biohorizonscamlog.es Headquarters CAMLOG Biotechnologies GmbH | Margarethenstr. 38 | Basilea | Suiza Teléfono +41 61 565 41 00 | Fax +41 61 565 41 01 | info@camlog.com | www.biohorizonscamlog.com CeraOss® HYA, PermaPro®, Argonaut®, cerabone® y cerabone® plus son fabricados por botiss biomaterials GmbH. Todos los nombres de los productos, aparezcan o no en letras grandes o con el símbolo de marca registrada, son marcas registradas de BioHorizons Inc. o CAMLOG Biotechnologies GmbH, sus filiales, empresas vinculadas o sus licenciantes, salvo que se indique lo contrario. cerabone® es una marca registrada de botiss biomaterials GmbH. Algunas marcas pueden no estar registradas en todos los mercados. Todos los derechos reservados. No todos los productos están disponibles en todos los países. Ref. Volumen Partícula BM1015.1005 0.5 cm3 500–1000 µm BM1015.1010 1.0 cm3 500–1000 µm BM1016.1005 0.5 cm3 1000–2000 µm BM1016.1010 1.0 cm3 1000–2000 µm Los biomateriales no se pueden cambiar o devolver. Nuestros servicios y entregas se realizan exclusivamente bajo los Términos y Condiciones Generales. Referencias [1] Cerabone® plus usability test. [2] 78.5% of users reported easier or much easier application compared to particulate material without hyaluronic acid; Data on file: Customer survey among 156 clinicians. [3] Tadic et al. Comparison of different methods for the preparation of porous bone substitution materials and structural investigations by synchrotron μ-computer tomography. Mat.-wiss. u. Werkstofftech. 2004, 35, No. 4. [4] Seidel and Dingeldein 2004. cerabone® – Bovine Based Spongiosa Ceramic Seidel et al. Mat.-wiss. u. Werkstofftech. 35:208–212. [5] Kyyak et al. Hyaluronic Acid with Bone Substitutes Enhance Angiogenesis In Vivo. Materials (Basel) 2022. 15(11):3839. [6] Kyyak et al. The Influence of Hyaluronic Acid Biofunctionalization of a Bovine Bone Substitute on Osteoblast Activity In Vitro. Materials (Basel). 2021. 14(11):2885. [7] Qasim SSB, Trajkovski B, Zafiropoulos GG. The response of human osteoblasts on bovine xenografts with and without hyaluronate used in bone augmentation. J Biomater Sci Polym Ed. 2024 Apr;35(6):880-897. doi: 10.1080/09205063.2024.2311454. Epub 2024 Feb 12. PMID: 38346177. [8] Zhao, N., Wang, X., Qin, L., Zhai, M., Yuan, J., Chen, J., & Li, D. (2016). Effect of hyaluronic acid in bone formation and its applications in dentistry. Journal of biomedical materials research Part A, 104(6), 1560-1569. [9] Tawil et al. 2018. Sinus Floor Elevation Using the Lateral Approach and Window Repositioning and a Xenogeneic Bone Substitute as a Grafting Material: A Histologic, Histomorphometric, and Radiographic Analysis. Int J Oral Maxillofac Implants.33(5):1089-1096. [10] Riachi et al. 2012. Influence of material properties on rate of resorption of two bone graft materials after sinus lift using radiographic assessment. Int J Dent. 2012:737262. [11] Kloss et al. First Clinical Case Report of a Xenograft-Allograft Combination for Alveolar Ridge Augmentation Using a Bovine Bone Substitute Material with Hyaluronate (Cerabone® Plus) Combined with Allogeneic Bone Granules (Maxgraft®). J Clin Med. 2023. 12(19):6214. [12] Brown et al. New studies on the heat resistance of hamster-adapted scrapie agent: threshold survival after ashing at 600 degrees C suggests an inorganic template of replication, PNAS 2000. 97(7): 3418–3421. [13] Pröhl A et al. In Vivo Analysis of the Biocompatibility and Bone Healing Capacity of a Novel Bone Grafting Material Combined with Hyaluronic Acid. Int J Mol Sci. 2021. 22(9):48 [14] Rakašević et al. Reconstructive Peri-Implantitis Therapy by Using Bovine Bone Substitute with or without Hyaluronic Acid: A Randomized Clinical Controlled Pilot Study. J Funct Biomater. 2023 Mar 8;14(3):149. [15] Rayahin, J. E., Buhrman, J. S., Zhang, Y., Koh, T. J., & Gemeinhart, R. A. (2015). High and low molecular weight hyaluronic acid differentially influence macrophage activation. ACS biomaterials science & engineering, 1(7), 481-493. [16] Pirnazar P. et al. ’Bacteriostatic effects of hyaluronic acid. Journal of Periodontology 1999. 70:370-374. [17] Håkansson et al. Regulation of granulocyte function by hyaluronic acid. In vitro and in vivo effects on phagocytosis, locomotion, and metabolism. J Clin Invest. 198066:298–305. [18] Wisniewski HG, Vilcek J. TSG-6: An IL-1/TNF-inducible protein with anti-inflammatory activity. Cytokine Growth Factor Rev. 1997. 8:143-56. [19] Larjava et al. Characterization of one phenotype of human periodontal granulation-tissue fibroblasts. J Dent Res. 1989. 68:20-25. [20] Bartold PM, Page RC. The effect of chronic inflammation on gingival connective tissue proteoglycans and hyaluronic acid. J Oral Pathol. 1986. 15:367-74. [21] Bertolami CN, Messadi DV. The role of proteoglycans in hard and soft tissue repair. Crit Rev Oral Biol Med. 1994. 5:311-37. [22] Ruggiero et al. Hyaluronidase activity of rabbit skin wound granulation tissue fibroblasts. J Dent Res. 1987. 66:1283-7. [23] Mendes et al. Sodium hyaluronate accelerates the healing process in tooth sockets of rats. Arch Oral Biol. 2008. 53:1155-62.
RkJQdWJsaXNoZXIy MTE0MzMw